Cart
sales@molnova.com
Calenduloside E
CAS No. 26020-14-4
Calenduloside E( —— )
Catalog No. M18321 CAS No. 26020-14-4
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 275 | In Stock |
|
| 10MG | 392 | In Stock |
|
| 25MG | 654 | In Stock |
|
| 50MG | 910 | In Stock |
|
| 100MG | 1228 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCalenduloside E
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
DescriptionCalenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26020-14-4
-
Formula Weight632.83
-
Molecular FormulaC36H56O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (158.02 mM)
-
SMILESCC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)O)O)C)C)C2C1)C)C(=O)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matsuda, H., et al.: Chem. Pharma. Bull., 46, 1399 (1998); Matsuda, H., et al.: Biol. Pharma. Bull., 20, 717 (1997)
molnova catalog
related products
-
DPDPE TFA
DPDPE TFA is selective δ-opioid receptor agonist peptide. Inhibits electrically stimulated contraction of mouse vas deferens in vitro (EC50 = 5.2 nM), and is antinociceptive in vivo.
-
ADL5859
ADL5859 is a potent, selective, orally bioavailable full agonist of δ opioid receptor with Ki of 0.84 nM and EC50 of 20 nM.
-
Ac-RYYRWK-NH2
Potent, selective partial agonist peptide for the NOP receptor (Ki = 0.71 nM). Selective over μ, δ and κ opioid receptors (IC50 > 4000 nM). Increases food intake in vivo.
